Eddie Patel Inc’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Eddie Patel Inc’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,795	Closed	-$218K	–	108
2025 Q4	$218K	Buy	+4,795	New	+$213K	0.16%	99

Other funds holding GNOM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

USCWA

U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return

Armis Advisers Atlanta, Georgia $1.09B AUM 22.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CFD

Creative Financial Designs Kokomo, Indiana $1.65B AUM 15.6% 1-Year Est. Return

Eddie Patel Inc's GNOM Position: Q1 2026 in Review

Eddie Patel Inc sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q1 2026, closing a stake of 4,795 shares — an estimated $218K sold.

Eddie Patel Inc first reported a position in GNOM in Q4 2025 and held it in 1 quarter. The position peaked at $218K in Q4 2025. 40 funds tracked by Wall St. Rank hold GNOM as of Q1 2026.

Eddie Patel Inc reported no remaining Global X Genomics & Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
Eddie Patel Inc sold 4,795 Global X Genomics & Biotechnology ETF shares in Q1 2026, an estimated $218K.
Eddie Patel Inc first reported a position in Global X Genomics & Biotechnology ETF in Q4 2025 and held it in 1 quarter.
Eddie Patel Inc's Global X Genomics & Biotechnology ETF position peaked at $218K in Q4 2025.
40 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2026.

Based on Eddie Patel Inc's 13F filing for Q1 2026, filed 11 May 2026.